MedPath
NMPA Approval

Lenacapavir Sodium Injection

国药准字HJ20240170

December 25, 2024

Drug Information

来那帕韦钠注射液

萨兰卡

注射剂

1.5ml:0.4635g(按C₃₉H₃₂ClF₁₀N₇O₅S₂计)

化学药品

December 25, 2024

December 24, 2029

Company Information

Applicant Company

Carrigtohill, County Cork, T45 DP77, Ireland

Manufacturing Company

PATHEON ITALIA SPA

Viale Gian Battista Stucchi 110, Monza, 20900, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

来那帕韦钠注射液 - NMPA 批准文号 | MedPath